Monograph Details
|
|
Gastrointestinal Tract
> Nausea
|
|
KYTRIL TABLETS |
| Manufacturer |
|
Roche Laboratories |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Selective 5-HT3 receptor antagonist. |
| Generic Name |
|
Granisetron HCl 1mg. |
| Also |
|
• KYTRIL
|
| Indications |
|
Prevention of nausea and vomiting associated with chemotherapy (including high-dose cisplatin), and with radiation (including total body irradiation and fractionated abdominal radiation). |
| Children |
|
Use IV form. |
| Adults |
|
Chemotherapy: give only on the days chemotherapy is given. 2mg up to 1 hour before chemotherapy; or, 1mg up to 1 hour before chemotherapy, then 1mg 12 hours after initial dose. Radiation: 2mg within 1 hour of radiation. |
| Precautions |
|
Abdominal surgery. May mask progressive ileus and/or gastric distention. Pregnancy (Cat.B). Nursing mothers. |
| Interactions |
|
Caution with drugs that affect CYP450. |
| Adverse Reactions |
|
Headache, asthenia, diarrhea, constipation. |
| How Supplied |
Inj 1mg/mL single-use vial (1mL)—1 Inj 1mg/mL multidose vial (4mL)—1 Inj 0.1mg/mL single-use vial (1mL)—5 Tabs—2, 20 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|